These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34966196)

  • 1. Association Between Metformin Use and Mortality among Patients with Type 2 Diabetes Mellitus Hospitalized for COVID-19 Infection.
    Ong AN; Tan CC; Cañete MT; Lim BA; Robles J
    J ASEAN Fed Endocr Soc; 2021; 36(2):133-141. PubMed ID: 34966196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin use and mortality and length of stay among hospitalized patients with type 2 diabetes and COVID-19: A multiracial, multiethnic, urban observational study.
    Miao E; Zhang K; Liu J; Lin J; Yoo D; George CJ
    Front Endocrinol (Lausanne); 2022; 13():1002834. PubMed ID: 36440189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study.
    Pérez-Belmonte LM; Torres-Peña JD; López-Carmona MD; Ayala-Gutiérrez MM; Fuentes-Jiménez F; Jorge Huerta L; Muñoz JA; Rubio-Rivas M; Madrazo M; Garcia MG; Montes BV; Sola JF; Ena J; Ferrer RG; Pérez CM; Ripper CJ; Lecumberri JJN; Acedo IEA; Canteli SP; Cosío SF; Martínez FA; Rodríguez BC; Pérez-Martínez P; Ramos-Rincón JM; Gómez-Huelgas R;
    BMC Med; 2020 Nov; 18(1):359. PubMed ID: 33190637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin Use in Relation to Clinical Outcomes and Hyperinflammatory Syndrome Among COVID-19 Patients With Type 2 Diabetes: A Propensity Score Analysis of a Territory-Wide Cohort.
    Wong CKH; Lui DTW; Lui AYC; Low MCH; Kwok ACY; Lau KTK; Au ICH; Xiong X; Chung MSH; Lau EHY; Cowling BJ
    Front Endocrinol (Lausanne); 2022; 13():810914. PubMed ID: 35321338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin use and mortality in patients with advanced chronic kidney disease: national, retrospective, observational, cohort study.
    Hung SC; Chang YK; Liu JS; Kuo KL; Chen YH; Hsu CC; Tarng DC
    Lancet Diabetes Endocrinol; 2015 Aug; 3(8):605-14. PubMed ID: 26094107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin Use in Diabetes Prior to Hospitalization: Effects on Mortality in Covid-19.
    Li J; Wei Q; Li WX; McCowen KC; Xiong W; Liu J; Jiang W; Marin T; Thomas RL; He M; Gongol B; Hepokoski M; Yuan JX; Shyy JY; Xiong N; Malhotra A
    Endocr Pract; 2020 Oct; 26(10):1166-1172. PubMed ID: 33471718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
    Salpeter S; Greyber E; Pasternak G; Salpeter E
    Cochrane Database Syst Rev; 2002; (2):CD002967. PubMed ID: 12076461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
    Salpeter S; Greyber E; Pasternak G; Salpeter E
    Cochrane Database Syst Rev; 2003; (2):CD002967. PubMed ID: 12804446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin use before COVID-19 vaccination and the risks of COVID-19 incidence, medical utilization, and all-cause mortality in patients with type 2 diabetes mellitus.
    Yen FS; Wang SI; Lin SY; Wei JC
    Diabetes Res Clin Pract; 2023 Jun; 200():110692. PubMed ID: 37156428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin is Associated with Decreased 30-Day Mortality Among Nursing Home Residents Infected with SARS-CoV2.
    Lally MA; Tsoukas P; Halladay CW; O'Neill E; Gravenstein S; Rudolph JL
    J Am Med Dir Assoc; 2021 Jan; 22(1):193-198. PubMed ID: 33232684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of lactic acidosis in type 2 diabetes patients using metformin: A case control study.
    Aharaz A; Pottegård A; Henriksen DP; Hallas J; Beck-Nielsen H; Lassen AT
    PLoS One; 2018; 13(5):e0196122. PubMed ID: 29738540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis.
    Luo P; Qiu L; Liu Y; Liu XL; Zheng JL; Xue HY; Liu WH; Liu D; Li J
    Am J Trop Med Hyg; 2020 Jul; 103(1):69-72. PubMed ID: 32446312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a need to reconsider the use of metformin in COVID-19 patients with type 2 diabetes mellitus?
    Lazarus G; Suhardi IP; Wiyarta E; Rasyidah RA; Barliana JD
    Int J Diabetes Dev Ctries; 2021 Jul; 41(3):377-382. PubMed ID: 33679040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Japanese regulatory action on metformin-associated lactic acidosis in type II diabetes patients.
    Hanatani T; Sai K; Tohkin M; Segawa K; Saito Y
    Int J Clin Pharm; 2015 Jun; 37(3):537-45. PubMed ID: 25822043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
    Salpeter S; Greyber E; Pasternak G; Salpeter E
    Cochrane Database Syst Rev; 2006 Jan; (1):CD002967. PubMed ID: 16437448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preadmission metformin use and mortality among intensive care patients with diabetes: a cohort study.
    Christiansen C; Johansen M; Christensen S; O'Brien JM; Tønnesen E; Sørensen H
    Crit Care; 2013 Sep; 17(5):R192. PubMed ID: 24018017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of preadmission metformin use and mortality in patients with sepsis and diabetes mellitus: a systematic review and meta-analysis of cohort studies.
    Liang H; Ding X; Li L; Wang T; Kan Q; Wang L; Sun T
    Crit Care; 2019 Feb; 23(1):50. PubMed ID: 30777119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of metformin use on total mortality in patients with type 2 diabetes and chronic obstructive pulmonary disease: A matched-subject design.
    Yen FS; Chen W; Wei JC; Hsu CC; Hwu CM
    PLoS One; 2018; 13(10):e0204859. PubMed ID: 30286138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between Metformin Use and Risk of Lactic Acidosis or Elevated Lactate Concentration in Type 2 Diabetes.
    Lee EY; Hwang S; Lee YH; Lee SH; Lee YM; Kang HP; Han E; Lee W; Lee BW; Kang ES; Cha BS; Lee HC
    Yonsei Med J; 2017 Mar; 58(2):312-318. PubMed ID: 28120561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term metformin use may improve clinical outcomes in diabetic patients with non-alcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis.
    Vilar-Gomez E; Vuppalanchi R; Desai AP; Gawrieh S; Ghabril M; Saxena R; Cummings OW; Chalasani N
    Aliment Pharmacol Ther; 2019 Aug; 50(3):317-328. PubMed ID: 31157422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.